GSA Capital Partners LLP Takes $1.23 Million Position in Colgate-Palmolive (NYSE:CL)

GSA Capital Partners LLP purchased a new stake in Colgate-Palmolive (NYSE:CL) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 17,175 shares of the company’s stock, valued at approximately $1,231,000.

Several other hedge funds and other institutional investors have also bought and sold shares of CL. Northern Trust Corp grew its stake in Colgate-Palmolive by 1.4% during the first quarter. Northern Trust Corp now owns 10,906,808 shares of the company’s stock valued at $747,553,000 after acquiring an additional 146,144 shares in the last quarter. Geode Capital Management LLC grew its stake in Colgate-Palmolive by 7.9% during the fourth quarter. Geode Capital Management LLC now owns 10,540,277 shares of the company’s stock valued at $626,200,000 after acquiring an additional 768,550 shares in the last quarter. FIL Ltd grew its stake in Colgate-Palmolive by 9.6% during the first quarter. FIL Ltd now owns 7,972,928 shares of the company’s stock valued at $546,465,000 after acquiring an additional 695,987 shares in the last quarter. FMR LLC grew its stake in Colgate-Palmolive by 29.1% during the first quarter. FMR LLC now owns 7,384,604 shares of the company’s stock valued at $506,141,000 after acquiring an additional 1,665,348 shares in the last quarter. Finally, OppenheimerFunds Inc. grew its stake in Colgate-Palmolive by 2.5% during the first quarter. OppenheimerFunds Inc. now owns 5,855,519 shares of the company’s stock valued at $401,337,000 after acquiring an additional 142,293 shares in the last quarter. 75.83% of the stock is currently owned by institutional investors.

Several brokerages recently commented on CL. ValuEngine cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Morgan Stanley boosted their price target on shares of Colgate-Palmolive from $72.00 to $74.00 and gave the stock an “equal weight” rating in a research note on Monday, July 29th. Macquarie boosted their price target on shares of Colgate-Palmolive from $65.00 to $72.00 and gave the stock a “neutral” rating in a research note on Monday, April 29th. Bank of America set a $80.00 price target on shares of Colgate-Palmolive and gave the stock a “buy” rating in a research note on Friday, July 12th. Finally, Jefferies Financial Group boosted their price target on shares of Colgate-Palmolive from $61.00 to $73.00 and gave the stock an “in-line” rating in a research note on Monday, April 29th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating and six have issued a buy rating to the company’s stock. Colgate-Palmolive has a consensus rating of “Hold” and a consensus price target of $73.87.

CL stock traded down $0.81 during midday trading on Friday, reaching $72.23. The company had a trading volume of 2,972,789 shares, compared to its average volume of 3,558,221. The company has a debt-to-equity ratio of 32.25, a current ratio of 1.13 and a quick ratio of 0.78. Colgate-Palmolive has a 1 year low of $57.41 and a 1 year high of $76.41. The company has a market capitalization of $62.67 billion, a P/E ratio of 24.32, a P/E/G ratio of 4.70 and a beta of 0.76. The firm has a 50-day moving average price of $72.56 and a 200-day moving average price of $70.11.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.72 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.72. The firm had revenue of $3.87 billion during the quarter, compared to analyst estimates of $3.88 billion. Colgate-Palmolive had a net margin of 14.77% and a negative return on equity of 10,821.98%. The business’s quarterly revenue was down .5% on a year-over-year basis. During the same period in the previous year, the business posted $0.77 EPS. On average, equities analysts predict that Colgate-Palmolive will post 2.84 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Thursday, July 18th were issued a $0.43 dividend. The ex-dividend date was Wednesday, July 17th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.38%. Colgate-Palmolive’s payout ratio is 57.91%.

In other news, SVP John J. Huston sold 473 shares of the business’s stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $72.93, for a total value of $34,495.89. Following the completion of the sale, the senior vice president now directly owns 59,668 shares in the company, valued at approximately $4,351,587.24. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Ian M. Cook sold 175,616 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $72.65, for a total transaction of $12,758,502.40. Following the completion of the sale, the insider now owns 1,125,842 shares of the company’s stock, valued at $81,792,421.30. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 564,285 shares of company stock valued at $40,530,290. Company insiders own 1.14% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Story: How much can an individual set aside as a catch-up contribution?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.